CCN2 and metabolic dysfunction-associated steatohepatitis: Highlighting the importance of this IGF2BP2-IL13-CTGF axis in pathology, blockade of the IL-13 receptor in a mouse nonalcoholic steatohepatitis (NASH) model reduced fibrosis [113].